Shopping Cart
Remove All
Your shopping cart is currently empty
NARS-3′ is an inhibitor of xanthine oxidase (XO), with an IC50 value of 21.01 μM. It competitively inhibits XO activity, thereby reducing uric acid production. Additionally, NARS-3′ helps mitigate renal damage and is applicable in hyperuricemia research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | NARS-3′ is an inhibitor of xanthine oxidase (XO), with an IC50 value of 21.01 μM. It competitively inhibits XO activity, thereby reducing uric acid production. Additionally, NARS-3′ helps mitigate renal damage and is applicable in hyperuricemia research. |
| In vitro | NARS-3′ (0-100 μM) exhibits dose-dependent inhibition of XO activity. At concentrations of 0-40 μM, NARS-3′ can bind to the active site of XO, competing with the xanthine substrate. It may also induce conformational changes in XO. |
| In vivo | NARS-3′ (25-100 mg/kg; oral administration; once daily; for one week) effectively inhibits serum XO activity induced by Potassium oxonate (PO) in hyperuricemic mice, reduces serum uric acid (UA) levels, and offers significant renal protection.' |
| Molecular Weight | 374.30 |
| Formula | C15H11NaO8S |
| Cas No. | 2702589-46-4 |
| Smiles | O=C1C2=C(OC(C1)C3=CC=C(C(S(=O)([O-])=O)=C3)O)C=C(O)C=C2O.[Na+] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.